The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients

URN to cite this document:: urn:nbn:de:bvb:355-epub-295268
DOI to cite this document:: 10.5283/epub.29526

Machleidt, Anna ; Buchholz, Stefan ; Diermeier-Daucher, S. ; Zeman, Florian ; Ortmann, Olaf ; Brockhoff, Gero

Preview

License: Creative Commons: Attribution 3.0
PDF - Published Version
(957kB)

Date of publication of this fulltext: 12 Feb 2014 12:26

Alternative links to fulltext:DOI

Details

Preview

Export bibliographical data

Abstract

Background Not only four but rather seven different humane pidermal growth factor receptor related (Her) receptor tyrosine kinases (RTKs) have been described to be expressed in a variety of normal and neoplastic tissues: Her1, Her2, Her3, and additionally four Her4 isoforms have been identified. A differential expression of Her4 isoforms does not, however, play any role in either the molecular ...